Our Purpose
A new approach to blood pumping
Levanta Flow S.L. is developing a magnetic liquid-wall blood-pump platform for extracorporeal life support, designed to reduce mechanical blood trauma.
Our development-stage platform uses a magnetically confined ferrofluid to form a liquid-in-liquid channel, with magnetic actuation moving blood without a conventional impeller contacting it. It is not approved or available for clinical use.


Development
The path toward clinical use
Current technology maturation: magnetic design, ferrofluid reproducibility, pump performance and blood compatibility. Planned device development: design controls, sterile cassette development, manufacturing and preclinical evaluation.
Planned clinical validation: verification and validation, clinical evaluation and regulatory submissions. Longer-term market expansion: EU market entry, a US pathway and further development of the ECLS platform. Objectives remain subject to technical results, financing and regulatory review.
Ecosystem
Science, clinical insight and company building


Founders
Scientific depth and execution
Levanta Flow combines life-sciences leadership with scientific expertise in liquid-tube technology.

Christophe Valat
CEO & Co-Founder
More than 20 years in life sciences, with experience in company creation, executive leadership, financing and business development.

Thomas M. Hermans
Scientific Co-Founder
IMDEA Senior Research Professor and inventor of liquid-tube technology, with expertise in ferrofluids, interfaces and magnetic actuation.
Contact the team
For investor, co-development, clinical or research discussions, please contact Levanta Flow.
Connect
Start a conversation
To learn more about Levanta Flow and our work in extracorporeal life-support technology, contact our team.
